SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001694665-20-000079
Filing Date
2020-07-31
Accepted
2020-07-31 11:12:52
Documents
64
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q evlo-20200630.htm   iXBRL 10-Q 1843438
2 EX-10.2 exhibit1022020q2.htm EX-10.2 89342
3 EX-31.1 eveloq22020exhibit311.htm EX-31.1 21825
4 EX-32.1 eveloq22020exhibit321.htm EX-32.1 11966
  Complete submission text file 0001694665-20-000079.txt   6066506

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evlo-20200630.xsd EX-101.SCH 40135
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT evlo-20200630_cal.xml EX-101.CAL 64064
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evlo-20200630_def.xml EX-101.DEF 159791
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evlo-20200630_lab.xml EX-101.LAB 510221
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evlo-20200630_pre.xml EX-101.PRE 301125
10 EXTRACTED XBRL INSTANCE DOCUMENT evlo-20200630_htm.xml XML 774739
Mailing Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139 617 870 8281
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38473 | Film No.: 201064429
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences